Sharps Technology, Inc. (STSS)
- Previous Close
5.00 - Open
6.11 - Bid 5.33 x 100
- Ask 7.20 x 100
- Day's Range
5.30 - 7.39 - 52 Week Range
3.30 - 5,445.00 - Volume
19,357,221 - Avg. Volume
686,190 - Market Cap (intraday)
91.633M - Beta (5Y Monthly) 2.08
- PE Ratio (TTM)
-- - EPS (TTM)
-2,220.00 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York.
sharpstechnology.comRecent News: STSS
View More
Performance Overview: STSS
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STSS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STSS
View MoreValuation Measures
Market Cap
91.47M
Enterprise Value
94.37M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
45.82
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-62.99%
Return on Equity (ttm)
-187.23%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-9.3M
Diluted EPS (ttm)
-2,220.00
Balance Sheet and Cash Flow
Total Cash (mrq)
864.04k
Total Debt/Equity (mrq)
188.55%
Levered Free Cash Flow (ttm)
-6.95M